Zobrazeno 1 - 10 of 47 916 pro vyhledávání: '"Fgfr2"'
1
Akademický článek
Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas.
Autor: Pu, Xiaohong1 (AUTHOR), Qi, Liang2 (AUTHOR), Yan, Jia Wu3 (AUTHOR), Ai, Zihe4 (AUTHOR), Wu, Ping4 (AUTHOR), Yang, Fei3 (AUTHOR), Fu, Yao1 (AUTHOR), Li, Xing5 (AUTHOR), Zhang, Min6 (AUTHOR), Sun, Beicheng3 (AUTHOR) sunbc@nju.edu.cn, Yue, Shen4 (AUTHOR) yueshen@njmu.edu.cn, Chen, Jun1 (AUTHOR) ichenjun@qq.com
Publikováno v: Cell & Bioscience. 11/14/2023, Vol. 13 Issue 1, p1-16. 16p.
Zobrazit plný text záznamu
2
Akademický článek
Deciphering the FGFR2 Code: Innovative Targets in Gastric Cancer Therapy.
Autor: Tojjari, Alireza1 (AUTHOR) alirezatojjari@gmail.com, Nagdas, Sarbajeet2 (AUTHOR) nagdass@upmc.edu, Saeed, Ali3 (AUTHOR) asaeedmd@gmail.com, Saeed, Anwaar1,2 (AUTHOR) saeeda3@upmc.edu
Publikováno v: Current Oncology. Aug2024, Vol. 31 Issue 8, p4305-4317. 13p.
Zobrazit plný text záznamu
3
Akademický článek
Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion.
Autor: He, Guo-qian1,2 (AUTHOR), Li, Qing3 (AUTHOR), Jing, Xiao-yu1,2 (AUTHOR), Li, Jian4 (AUTHOR) ianlly@163.com, Gao, Ju1,2,5 (AUTHOR) gaoju651220@126.com, Guo, Xia1,2,5 (AUTHOR) guoxkl@163.com
Publikováno v: Molecular Cancer. 12/6/2024, Vol. 23 Issue 1, p1-7. 7p.
Zobrazit plný text záznamu
4
Akademický článek
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.
Autor: Brandi, Giovanni1,2 (AUTHOR) giovanni.brandi@unibo.it, Relli, Valeria2,3 (AUTHOR), Deserti, Marzia2 (AUTHOR), Palloni, Andrea1 (AUTHOR), Indio, Valentina4 (AUTHOR), Astolfi, Annalisa2,5 (AUTHOR), Serravalle, Salvatore6 (AUTHOR), Mattiaccio, Alessandro2 (AUTHOR), Vasuri, Francesco7 (AUTHOR), Malvi, Deborah7 (AUTHOR), Deiana, Chiara1 (AUTHOR), Pantaleo, Maria Abbondanza1,2 (AUTHOR), Cescon, Matteo2,8 (AUTHOR), Rizzo, Alessandro9 (AUTHOR), Katoh, Masaru10,11 (AUTHOR), Tavolari, Simona1 (AUTHOR)
Publikováno v: Scientific Reports. 2/7/2024, Vol. 14 Issue 1, p1-13. 13p.
Zobrazit plný text záznamu
5
Akademický článek
Developing New Peptides and Peptide–Drug Conjugates for Targeting the FGFR2 Receptor-Expressing Tumor Cells and 3D Spheroids.
Autor: Biggs, Mary A.1 (AUTHOR) mbiggs2@fordham.edu, Das, Amrita1 (AUTHOR), Goncalves, Beatriz G.1 (AUTHOR), Murray, Molly E.1 (AUTHOR), Frantzeskos, Sophia A.1 (AUTHOR), Hunt, Hannah L.1 (AUTHOR), Phan, Chau Ahn N.1 (AUTHOR), Banerjee, Ipsita A.1 (AUTHOR) banerjee@fordham.edu
Publikováno v: Biomimetics (2313-7673). Sep2024, Vol. 9 Issue 9, p515. 28p.
Zobrazit plný text záznamu
6
Akademický článek
Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion
Autor: Guo-qian He, Qing Li, Xiao-yu Jing, Jian Li, Ju Gao, Xia Guo
Publikováno v: Molecular Cancer, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Combined hepatocellular-cholangiocarcinoma (cHCC-CCA), an extremely rare and underinvestigated subtype of primary liver cancer in children, generally has a poor prognosis and greater aggressiveness. Histological diagnosis of cHCC-CCA is diff
Externí odkaz: https://doaj.org/article/db2b96e8b9a54b658dbab57ff3bd651d
Zobrazit plný text záznamu
7
Akademický článek
FGFR2 modulates the Akt/Nrf2/ARE signaling pathway to improve angiotensin II-induced hypertension-related endothelial dysfunction.
Autor: Kun Jiao1, Ping Su1, Yongling Li1 Liyongling921011@163.com
Publikováno v: Clinical & Experimental Hypertension. Dec2023, Vol. 45 Issue 1, p1-10. 10p.
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Challenges of FGFR2 Testing in Gastric Cancer.
Autor: Tsimafeyeu, Ilya1 tsimafeyeu@gmail.com, Raskin, Grigory2
Publikováno v: Oncology Reviews. 2023, p1-4. 4p.
Zobrazit plný text záznamu
10
Akademický článek
Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification.
Autor: Yuan, Jiajia1 (AUTHOR), Shen, Lin1 (AUTHOR), Liu, Tian Shu2 (AUTHOR), Xu, HuiTing3 (AUTHOR), Yang, Jianwei4 (AUTHOR), Wei, Jia5 (AUTHOR), Jiang, Haiping6 (AUTHOR), Deng, Yanhong7 (AUTHOR), Pan, Hongming8 (AUTHOR), Wang, Yusheng9 (AUTHOR), Zhang, Xiaotian1 (AUTHOR), Peng, Zhi1 (AUTHOR), Qi, Changsong1 (AUTHOR), Zhang, Lingli10 (AUTHOR), Hsu, Peiwen10 (AUTHOR), Song, Lin10 (AUTHOR), Mu, Lei10 (AUTHOR), Sun, Qiao10 (AUTHOR), Gong, Jifang1 (AUTHOR) goodjf@163.com, Lyu, Cheng10 (AUTHOR) levvy.lv@aliyun.com
Publikováno v: CTS: Clinical & Translational Science. Dec2024, Vol. 17 Issue 12, p1-11. 11p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje